Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2026-01-01 @ 3:28 AM
Study NCT ID:
NCT04635995
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-31
First Post:
2020-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Sponsor:
Lyvgen Biopharma Holdings Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LVGN7409-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None